According to Syndicate Market Research, the global Blood and Blood Components Market hit about USD 13.7 billion in 2024. The Blood and Blood Components Market industry is expected to reach around USD 14.2 billion in 2025 and a whopping USD 20.2 billion by 2034, growing at a steady compound annual growth rate (CAGR) of roughly 4% from 2026 to 2034. The report analyzes the Blood and Blood Components Market's drivers, restraints, and the impact it has on demand during the forecast period. Furthermore, it will assist in navigating and exploring emerging market prospects.
The global Blood and Blood Components Market encompasses the collection, processing, storage, distribution, and transfusion of whole blood along with its separated components such as red blood cells, platelets, plasma, and cryoprecipitate, which are vital for life-saving medical interventions in hospitals, blood banks, and surgical centers worldwide. These products address critical needs in treating blood loss, clotting disorders, immune deficiencies, and various chronic conditions through safe and compatible transfusions.
The market is propelled by the rising number of surgical procedures, trauma cases, and chronic illnesses requiring regular transfusions, alongside growing awareness of voluntary blood donation programs. However, restraints include persistent blood supply shortages, stringent regulatory requirements for safety testing, and risks of transfusion-transmitted infections. Key trends involve adoption of automated apheresis systems, pathogen inactivation technologies, and advanced storage solutions that enhance component shelf life and transfusion safety.
Key Insights
Growth Drivers • Rising incidence of chronic diseases and surgical procedures
The growing global burden of cancer, cardiovascular diseases, and anemia has significantly increased the demand for regular blood transfusions and specific components, creating sustained volume growth across hospitals and specialized treatment centers. Aging populations in developed nations further amplify this need, as elderly patients often require multiple transfusions during complex medical interventions.
Government-led blood donation awareness campaigns and improved collection infrastructure in emerging economies have also boosted supply availability, enabling broader market penetration and supporting consistent revenue growth for component manufacturers and blood banks.
Restraints • Blood supply shortages and stringent safety regulations
Many regions continue to face periodic blood shortages due to declining donor participation, seasonal fluctuations, and logistical challenges in collection and distribution, directly limiting market expansion despite rising clinical demand. Compliance with rigorous testing protocols for infectious diseases and quality standards adds substantial operational costs and delays for blood centers and processors.
Additionally, public concerns over transfusion risks and the high cost of advanced pathogen reduction technologies further constrain adoption rates in cost-sensitive markets.
Opportunities • Advancements in pathogen inactivation and automated collection technologies
Emerging opportunities exist in the integration of next-generation pathogen reduction systems and automated apheresis equipment, which enhance component safety and yield while reducing processing time and contamination risks for manufacturers and blood banks. Strategic partnerships between blood organizations and biotech firms for recombinant alternatives and extended-shelf-life solutions are expected to open premium revenue streams.
Expansion of plasma fractionation capacity in Asia Pacific and Latin America, combined with rising medical tourism for advanced therapies, presents significant untapped potential for both cellular components and plasma-derived products.
Challenges • Transfusion-related risks and supply chain complexities
The market faces ongoing challenges from rare but serious transfusion reactions, alloimmunization, and emerging pathogens that require continuous investment in screening and mitigation technologies, increasing overall costs and operational complexity. Global supply chain disruptions, including raw material shortages for storage bags and testing kits, add further pressure on consistent availability.
Maintaining equitable access across rural and urban areas while complying with varying international regulatory frameworks continues to pose logistical and ethical hurdles for stakeholders.
| Report Attributes | Report Details |
|---|---|
| Report Name | Blood and Blood Components Market |
| Market Size in 2024 | USD 13.7 Billion |
| Market Size in 2025 | USD 14.2 Billion |
| Market Forecast in 2034 | USD 20.2 Billion |
| Growth Rate (2026-2034) | CAGR of 4% |
| Base Year | 2025 |
| Historical Year | 2020 - 2024 |
| Forecast Year | 2026 - 2034 |
| Number of Pages | 225 |
| Report Coverage | Revenue Forecast, Market Dynamics, Company Profile, Competitive Landscape, Recent Developments, Growth Factors, and Recent Trends |
| Key Companies Covered | CSL Limited, Grifols S.A., Takeda Pharmaceutical Company Limited, and Others. |
| Segments Covered | By Product Type, By Application, By End-User, and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, and The Middle East and Africa (MEA) |
| Customization Scope | Customization for Segments, Region, Country-level will be provided. Avail customized purchase options to meet your exact research needs. Request For Customization |
The Blood and Blood Components Market is segmented by product type, application, end-user, and region.
Based on Product Type Segment, The Blood and Blood Components Market is divided into Red Blood Cells, Plasma, Platelets, Whole Blood, and others. Red Blood Cells represent the most dominant segment with approximately 55% market share primarily because they constitute the highest transfusion volume for oxygen-carrying support in trauma, surgery, and anemia cases, directly driving market stability through standardized high-demand protocols; this dominance helps drive overall market growth by ensuring reliable supply chains for life-critical interventions. Plasma is the second most dominant segment owing to its critical role in producing essential derivatives like immunoglobulins and clotting factors, thereby driving market expansion by catering to specialized therapies for bleeding disorders and immune deficiencies while commanding premium pricing.
Based on Application Segment, The Blood and Blood Components Market is divided into Trauma and Surgery, Anemia, Cancer Treatment, Bleeding Disorders, and others. Trauma and Surgery dominates the application segment with around 40% share owing to the massive requirement for immediate transfusions during emergencies and operative procedures across trauma centers and operating rooms; this segment drives the market by generating urgent, high-volume orders that prioritize rapid component availability and compatibility testing. Anemia holds the second position as chronic and chemotherapy-induced cases require repeated red cell support, helping expand market reach through long-term patient management programs in oncology and hematology departments.
Based on End-User Segment, The Blood and Blood Components Market is divided into Hospitals, Blood Banks, Ambulatory Surgical Centers, and others. Hospitals dominate with approximately 70% share due to their centralized role in acute care, complex surgeries, and on-site transfusion services that demand bulk and diversified component inventories; this directly drives market volume through institutional contracts and 24/7 operational needs. Blood Banks are the second most dominant segment as they serve as primary collection and distribution hubs, supporting market expansion by maintaining national and regional stockpiles and facilitating inter-hospital transfers.
In 2025, leading blood organizations in North America rolled out nationwide pathogen inactivation systems for platelets and plasma, significantly reducing transfusion-transmitted infection risks and prompting large-scale adoption by hospitals across the region.
A major industry player introduced advanced automated apheresis platforms capable of higher-yield platelet collection with shorter processing times, capturing substantial contracts from European blood banks and improving overall component availability.
Strategic collaboration between two global plasma fractionators and a biotech firm in early 2026 resulted in expanded production facilities for albumin and immunoglobulins, addressing growing demand for immune therapies and strengthening supply chains in Asia Pacific markets.
Regulatory approvals for extended-storage red blood cell solutions using new additive formulations were granted in several countries, allowing blood banks to reduce wastage and extend shelf life, which directly boosted operational efficiency and market revenues.
North America to dominate the global market
North America leads the global Blood and Blood Components Market with the highest share due to its sophisticated healthcare infrastructure, high volume of surgical and trauma procedures, and well-established voluntary donation systems. The United States dominates the regional landscape as the largest consumer and innovator, supported by advanced blood banks, strong reimbursement policies, and widespread adoption of cutting-edge pathogen reduction technologies across major hospital networks.
Europe follows with robust growth driven by unified regulatory frameworks and high awareness of blood safety standards. Germany and the United Kingdom dominate the European market through extensive public blood services, aging populations requiring frequent transfusions, and active investment in automated collection systems.
Asia Pacific is experiencing rapid expansion fueled by rising healthcare investments, growing surgical volumes, and government-supported blood donation drives. China and India dominate the region with their massive population base, increasing trauma care facilities, and emerging plasma fractionation plants that cater to both domestic needs and export markets.
Latin America shows steady progress supported by improving healthcare access and rising medical tourism. Brazil and Mexico dominate through expanding hospital networks and national blood programs that focus on enhancing component availability in urban centers while addressing rural supply gaps.
The Middle East and Africa region demonstrates promising potential driven by infrastructure development and increasing awareness of transfusion medicine. South Africa and Saudi Arabia dominate through modern blood banks and government initiatives aimed at building self-sufficient supply chains for trauma and chronic disease management.
Some of the significant players in the global Blood and Blood Components Market include;
By Product Type
By Application
By End-User
By Region
Frequently Asked Questions
What is Blood and Blood Components Market? The Blood and Blood Components Market refers to the global industry engaged in the collection, separation, processing, storage, and clinical use of whole blood and its derived components such as red blood cells, platelets, and plasma for therapeutic transfusions and specialized treatments.
What are the principal factors expected to drive expansion in the Blood and Blood Components Market between 2026 and 2034? Key drivers include rising surgical procedures and trauma cases, increasing prevalence of chronic diseases requiring transfusions, growing adoption of plasma-derived therapies, and advancements in automated collection and pathogen inactivation technologies.
What is the projected market size of the Blood and Blood Components Market from 2026 to 2034? (add both values) The market is projected to grow from approximately USD 14.8 billion in 2026 to USD 20.2 billion by 2034.
What overall growth rate (CAGR) is the Blood and Blood Components Market predicted to achieve between 2026 and 2034? (full answers) The Blood and Blood Components Market is predicted to achieve a compound annual growth rate (CAGR) of 4% between 2026 and 2034, supported by steady demand from healthcare facilities and continuous improvements in blood safety protocols.
Which geographic region is forecasted to be a leading contributor to the overall Blood and Blood Components Market valuation? North America is forecasted to be the leading contributor owing to its advanced medical infrastructure, high procedure volumes, and strong emphasis on transfusion safety standards.
Who are the top companies dominating and driving the Blood and Blood Components Market forward? Leading companies include CSL Limited, Grifols S.A., Takeda Pharmaceutical, Octapharma AG, and Terumo BCT, which are advancing innovation, expanding fractionation capacity, and strengthening global distribution networks.
What key information or findings can typically be expected from the global Blood and Blood Components Market report? The report delivers detailed insights on market size and forecast, segmentation breakdowns, regional performance, competitive landscape, recent technological advancements, growth drivers, restraints, and emerging opportunities.
What are the various stages in the value chain of the global Blood and Blood Components Market industry? The value chain covers donor recruitment and screening, blood collection and apheresis, component separation and processing, infectious disease testing, specialized storage and transportation, hospital or blood bank distribution, and post-transfusion monitoring.
How are current market trends and evolving consumer preferences influencing the Blood and Blood Components Market? Trends toward safer, pathogen-reduced components and personalized transfusion medicine are shaping preferences, while patients and providers increasingly demand traceable, high-quality products that minimize risks and improve therapeutic outcomes.
What regulatory changes or environmental factors are impacting the growth of the Blood and Blood Components Market? Stricter global standards for donor screening, pathogen inactivation mandates, and extended producer responsibility for blood bags are driving innovation, while climate-related disruptions to donation drives and supply logistics influence regional availability.
These players adopted different strategies so as to hold major market share in this market. Some of the major players in [keyword] industry includes. [players list]
Based on the [keyword] market analysis, North America is predicted to held the highest share in the [keyword] market during the forecast period.
The statistical data of the top market players of [keyword] industry can be obtained from the company profile section specified in the report. This section incorporates analysis of top player’s operating in the [keyword] industry as well as their last five-year revenue, segmental revenue, product offerings, key strategies adopted, and geographical revenue produced.
The study offers a decisive view on the [keyword] by segmenting the market based on [segment1], [segment2], and region.
The report gives a nitty-gritty assessment of the market by featuring data on various viewpoints that incorporate drivers, restraints, opportunities, and threats. This data can assist stakeholders in making suitable decisions before investing.
The sample for [keyword] market report can be received on-demand from the website as and when required.Direct call services or 24*7 chat support are provided to procure the sample report.
1.1 Research Methodology
The process of market research at Syndicate Market Research is an iterative in nature and usually follows following path. Information from secondary is used to build data models, further the results obtained from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new information is again incorporated into data model. The process continues till desired level of information is not generated.
To calculate the market size, the report considers the revenue generated from the sales of the market providers. The revenue generated from the sales of market is calculated through primary and secondary research. The key players operating in the market across the globe are identified through secondary research and a corresponding detailed analysis of the top vendors in the market is done. The market size calculation also includes clinical trial phase segmentation determined using secondary sources and verified through primary sources.
1.2 Secondary Research
The secondary research sources that are typically referred to include, but are not limited to:
The sources for secondary research includes but is not limited to: Factiva, Hoovers and Statista
1.3 Primary Research
We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
The participants who typically take part in such a process include, but are not limited to:
1.4 Models
Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data types to produce estimates:
Data is then cross checked by the expert panel.
1.4.1 Company Share Analysis Model
Company share analysis is used to derive the size of global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps:
1.4.2 Revenue Based Modeling
Revenue based models can be built in two ways - Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
1.5 Research Limitations
Inflation is not a part of pricing in this report. Prices of the products and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each type has been taken into account while estimating and forecasting market revenue on a global basis. Regional average price has been considered while breaking down this market by end user in each region.
We focus on the quality and accuracy of the report
Our expert team will assist with all your research needs and customize the report
Get you queries resolved from our expert analysts before and after purchasing the report
Instant delivery in the form of a PDF/PPT/Word Doc to your email address, within 12 hours after receiving the full payment.
Analysts will provide deep insights about the reports
* We value your privacy and will never rent or sell your email address.
Comprehensive & Focused Market Reports Large Archive of Excellent Market and Industry Analysis Reports that Deliver Business Intelligence.
Safe & Secure Payment Solutions
Enabled by SSL, we provide you numerous safe payment options for
risk-free transactions.
Superior Customer Experience We serve our
customers through calls, emails and live chats for 365 days, 24x7.
Syndicate Market Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. Read More
We accept the following payment methods
